• isi_ọkọlọtọ_01

20mg Retatrutide Arọ Mbelata Peptide Lyophilized Powder Reta Vials Injection 99% Retatrutide

Nkọwa dị mkpirikpi:

Ịdị ọcha:>99%

Nkọwa: 20mg

Steeti: Lyophilized ntụ ntụ

Ngwungwu njem: 10vials/igbe

Ọdịdị: White ntụ ntụ


Nkọwa ngwaahịa

Mkpado ngwaahịa

Nkọwa ngwaahịa

Aha  Retatrutide
Steeti Lyophilized ntụ ntụ
Ọdịdị Ọcha ntụ ntụ 
Ọkwa Ọkwa ahụike
Ịdị ọcha 99%
Nha 10mg, 20mg, 30mg, 60mg
nchịkwa Ọgwụ n'okpuru akpụkpọ ahụ
Uru Ịgwọ ọrịa shuga mellitus na mbelata ibu

Nkọwa ngwaahịa
Retatrutide bụ peptide agonist ọhụrụ nke na-ezubere onye na-anabata glucagon (GCGR), nnabata insulinotropic polypeptide na-anabata glucose (GIPR), na onye na-anabata glucagon dị ka peptide-1 (GLP-1R). Retatrutide na-arụ ọrụ GCGR, GIPR, na GLP-1R mmadụ nwere ụkpụrụ EC50 nke 5.79, 0.0643, na 0.775 nM, n'otu n'otu, na òké GCGR, GIPR, na GLP-1R nwere ụkpụrụ EC50 nke 2.32, 0.0.41, na Ọ na-eje ozi dị ka ngwá ọrụ nyocha dị mkpa na ọmụmụ banyere oke ibu na nsogbu metabolic.

Retatrutide na-arụ ọrụ nke ọma n'ụzọ mgbaàmà GLP-1R ma na-akpali mmepụta insulin dabere na glucose site n'ime ma GIP na GLP-1 ndị na-anabata ya. Nke a peptide sịntetik na-egosipụta ikike hypoglycemic nwere ike ma mepụta ya dị ka ihe mgbochi ọrịa shuga maka ụdị ọrịa shuga 2 (T2D). Ọ na-akwalite mwepụta insulin ma na-ebelata glucagon secretion na-adabere na glucose.

Na mgbakwunye, egosipụtara na Retatrutide na-egbu oge mkpofu afọ, na-ebelata ma ibu ọnụ na ọkwa glucose postprandial, belata oriri oriri, ma na-ebute oke ibu ahụ na ndị nwere T2D.

Ọrụ ndu
Retatrutide (LY3437943) bụ otu peptide nwere conjugated lipid nke na-arụ ọrụ dị ka agonist dị ike nke GCGR mmadụ, GIPR na GLP-1R. E jiri ya tụnyere glucagon mmadụ na GLP-1, Retatrutide na-egosipụta ike dị ala na GCGR na GLP-1R (0.3 × na 0.4 ×, n'otu n'otu) mana na-egosipụta ike nke ọma (8.9 ×) na GIPR ma e jiri ya tụnyere glucose-based insulinotropic polypeptide (GIP).

Usoro nke Omume
N'ime ọmụmụ ihe metụtara oke ọrịa shuga nwere nephropathy, nchịkwa Retatrutide belatara nke ukwuu albuminuria yana mmụba nzacha glomerular. A na-ekwu na mmetụta nchebe a sitere na ịgbalite ụzọ mgbaàmà GLP-1R/GR, nke na-eme ka ihe mgbochi mkpali na mgbochi apoptotic na anụ ahụ akwara.

Retatrutide na-agbanwekwa permeability glomerular ozugbo, na-eme ka ikike itinye uche na mmamịrị dịkwuo mma. Nchoputa nke mbu na-egosi na, ma e jiri ya tụnyere ọgwụgwọ ọrịa akụrụ na-adịghị ala ala nke dị ka ACE inhibitors na ARBs, Retatrutide na-emepụta mbelata nke ukwuu na albuminuria mgbe naanị izu anọ gasịrị. Ọzọkwa, ọ egosipụtala ịdị irè dị ukwuu n'ibelata ọbara mgbali systolic karịa ndị na-egbochi ACE ma ọ bụ ARB, na-enweghị mmetụta ọjọọ ọ bụla a hụrụ.

Mmetụta dị n'akụkụ
Mmetụta kachasị emetụta Retatrutide bụ eriri afọ na ọdịdị, gụnyere ọgbụgbọ, afọ ọsịsa, vomiting, na afọ ntachi. Mgbaàmà ndị a na-adịkarị nwayọọ ma na-agafeghị oke ma na-edozi ya site na mbelata dose. Ihe dị ka 7% nke isiokwu ahụ kọkwara mmetụta nke nrịanrịa akpụkpọ ahụ. A hụrụ mmụba nke obi obi na izu 24 n'ime ìgwè ndị dị elu, nke mesịrị laghachi na ọkwa mmalite.

Ike Retatrutide maka ibu ibu

Reta 10mg 20mg 30mg 60mg Retatrutide injection maka ibu ibu


  • Nke gara aga:
  • Osote:

  • Dee ozi gị ebe a ziga anyị ya